News Releases Medical/Health Care

Translations:

MIAMI, August 14, 2018 /PRNewswire-AsiaNet/ -- ArisGlobal, a leading life sciences technology provider, announced that Dohmen Life Science Services (DLSS) [https://goo.gl/xycVUA], a leading provider of outsourced commercialization services within the life sciences industry, selected LifeS...

BOONE, North Carolina, Aug. 13, 2018 /PRNewswire-AsiaNet/ -- Pneuma Respiratory, Inc., which has developed PNEUMAHALER(TM), the first breath-activated digital inhaler (BDI), announced that Haisco Pharmaceutical Group Co Ltd, a China-based company focused on the research and development and marketing of ther...

SEOUL, South Korea, Aug. 13, 2018 /PRNewswire-AsiaNet/ -- - In Collaboration with Seoul Metropolitan Government and KHIDI
- QuickFire Challenge seeks to identify and accelerate game-changing, early-stage innovations in the areas of robotics and digital surgery from around the world.
- Winners will rec...

PARIS, July 31, 2018 /PRNewswire-AsiaNet/ -- Released today, a new report based on research by the Economist Intelligence Unit (EIU) and sponsored by Pfizer Vaccines assesses why, despite the evidence supporting the medical and cost-saving benefits of preventative healthcare measures, consu...

SHENZHEN, China, Aug. 8, 2018 /PRNewswire-AsiaNet/ -- TIENS Group, one of leading corporations in the Healthcare industry, unveiled a new high-tech Customer Experience Store in Shenzhen. Li Jinyuan, founder and chairman of TIENS group, announced the official opening of its first store in the world on...

ROME, Aug. 6, 2018, /PRNewswire-AsiaNet/-- Menarini Ricerche, a company of the Menarini Group, announced today that the sponsorship of the ongoing Phase I/II study that is investigating MEN1703/SEL24 for the treatment of patients with relapsed/refractory (R/R) AML in the USA has been trans...

LONDON, August 3, 2018 /PRNewswire-AsiaNet/ -- Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet Neurology[1].
Treatment with APO-go®/MOVAPO® (apomorphine) subcutaneous infusion for 12 weeks gave significan...

SEOUL, South Korea, Aug. 2, 2018 /PRNewswire-AsiaNet/ -- - Direct sharing of symptoms and treatment processes and provision of compensation for the sharing of information.
- Expected to release blockchain-based "Humanscape" later this year.
Today, more and more people are suffering from serious, i...